Abstract
Background Globally, smoking leads to over 7 million preventable deaths annually, with higher rates in men (16%) than women (7%). While smoking has declined in high-income countries, tobacco use in Rwanda is comparatively low, affecting 14% of men and 3% of women.
Objective The study aimed to identify the factors associated with tobacco smoking among workers and their spouses in Rwanda.
Method This research employed a cross-sectional study design conducted in a beverage manufacturing industry in Rwanda. The target population was 822 participants, including industry employees and their spouses, aged 30 to 75 years. Using the Cochrane formula, the initial sample size was determined to be 384, and after the non-response rate adjustment and correction, the final sample size was set at 440. The data collection was carried out from May to December 2018. A combination of stratified and simple random sampling was used to ensure the sample’s representativeness.
Results The analysis reveals 6.8% were smokers and several key predictors of smoking behavior. Participants with elevated cardiovascular disease (CVD) risk (≥10%) have significantly higher odds of smoking, with an adjusted odds ratio of 2.946 (95% CI: 1.102-7.875, p=0.03), suggesting that CVD risk is a crucial factor in smoking behavior due to overlapping lifestyle risks. Additionally, high serum uric acid (SUA) levels (≥7 mg/dl) are strongly associated with smoking, with an adjusted odds ratio of 4.278 (95% CI: 1.141-11.872, p=0.005), indicating that elevated SUA levels are over four times more likely to be linked to smoking. Age is another significant predictor, with participants aged 50 years or older being nearly three times more likely to smoke compared to younger individuals, as shown by an adjusted odds ratio of 2.766 (95% CI: 1.126-6.797, p=0.02). Participants with hypertension or those treated for hypertension have lower adjusted odds ratio of 0.380 (95% CI: 0.100-1.446, p=0.049).
Conclusion The study found that tobacco smoking is relatively rare in this population, with elevated cardiovascular disease risk. High serum uric acid levels, and older age identified as significant predictors of smoking.
What is already known on this topic Tobacco smoking is a major global cause of preventable deaths, with higher smoking rates in men, and although smoking has declined in high-income countries, tobacco use remains relatively low in Rwanda.
What this study adds The study identifies key factors associated with smoking among industrial workers and their spouses in Rwanda, including elevated cardiovascular disease risk, high serum uric acid levels, and older age.
How this study might affect research, practice, or policy This study highlights important predictors of smoking in a Rwandan context, which could inform targeted public health strategies, smoking cessation programs, and policy decisions aimed at reducing tobacco use.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no financial support provided for conducting this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was carried out in accordance with the Declaration of Helsinki and was approved by the Rwanda National Ethical Committee (Reference number: 121/May/RNEC/2018). The ethical aspects, including confidentiality, voluntary participation, the option to withdraw, and the potential risks and benefits, were explained to all participants. Informed consent was obtained from each participant before the interviews and collection of biological samples took place.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All data related to this manuscript has been provided within this publication.
